0001127602-18-003823.txt : 20180202 0001127602-18-003823.hdr.sgml : 20180202 20180202172105 ACCESSION NUMBER: 0001127602-18-003823 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180131 FILED AS OF DATE: 20180202 DATE AS OF CHANGE: 20180202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greene John CENTRAL INDEX KEY: 0001610732 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37859 FILM NUMBER: 18571908 MAIL ADDRESS: STREET 1: 51 LIME STREET CITY: LONDON STATE: X0 ZIP: EC3M 7DQ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bioverativ Inc. CENTRAL INDEX KEY: 0001681689 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813461310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 2ND AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-663-4400 MAIL ADDRESS: STREET 1: 225 2ND AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-01-31 0001681689 Bioverativ Inc. BIVV 0001610732 Greene John BIOVERATIV INC. 225 2ND AVE. WALTHAM MA 02451 1 EVP, CFO and Treasurer Restricted Stock Units 2018-01-31 4 A 0 42727 0 A Common Stock 42727 42727 D Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in three equal annual installments beginning on January 31, 2019. /s/ Matthew S. Gilman, Attorney in Fact for John Greene 2018-02-02